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Abstract: The in utero and early postnatal environments play essential roles in offspring growth and
development. Standardizing or reducing pup litter size can independently compromise long-term
health likely due to altered milk quality, thus limiting translational potential. This study investigated
the effect reducing litter size has on milk quality and offspring outcomes. On gestation day 18,
dams underwent sham or bilateral uterine vessel ligation surgery to generate dams with normal
(Control) and altered (Restricted) milk quality/composition. At birth, pups were cross-fostered onto
separate dams with either an unadjusted or reduced litter size. Plasma parathyroid hormone-related
protein was increased in Reduced litter pups, whereas ionic calcium and total body calcium were
decreased. These data suggest Reduced litter pups have dysregulated calcium homeostasis in
early postnatal life, which may impair bone mineralization decreasing adult bone bending strength.
Dams suckling Reduced litter pups had increased milk long-chain monounsaturated fatty acid and
omega-3 docosahexaenoic acid. Reduced litter pups suckled by Normal milk quality/composition
dams had increased milk omega-6 linoleic and arachidonic acids. Reduced litter male adult offspring
had elevated blood pressure. This study highlights care must be taken when interpreting data from
research that alters litter size as it may mask subtle cardiometabolic health effects.
Keywords: reduced litter size; postnatal calcium homeostasis; adult bone health; milk composition
1. Introduction
It is well known that the in utero and early postnatal environments play crucial roles in offspring
growth, development and long-term health. David Barker first demonstrated a causal link between size
at birth and later-life cardiovascular disease [1,2], which has been since expanded to include several
adverse pregnancy perturbations, including fetal growth restriction [3,4], maternal undernutrition [5,6],
maternal alcohol consumption [7,8] and maternal stress [9,10]. Postnatal growth rate and development
is directly proportional to the quality and quantity of milk produced and is particularly influenced by
fatty acid composition [11]. Specifically, high intakes of omega-3 fatty acids in early postnatal life is
associated with reduced fat deposition and improved cardiometabolic health [12,13].
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More recent experimental studies have demonstrated that altered maternal nutrition during the
lactation period can program adult offspring cardiometabolic disease. Specifically, pups suckled by
dams fed a cafeteria diet during lactation exhibit a “thin-outside-fat-inside phenotype” (lean with
increased abdominal fat) and impaired metabolic health in adulthood [14]. Whereas, male offspring
cross-fostered onto a dam fed an isocaloric low-protein diet (6% protein) throughout pregnancy and
lactation have increased blood pressure and renal dysfunction [15,16]. As milk is the sole source of
nutrition during early postnatal life, these studies strongly support a role for altered milk quality
and/or quantity as a mechanism through which maternal nutritional status during lactation influences
offspring disease.
In the developmental programming field, many researchers standardize or reduce litter size at
birth to normalize milk intake across pups and cohorts [17], with the degree of litter size reduction
dependent on the experimental model and research question [18–25]. A previous study identified
that pup body weight and development during lactation is dependent on litter size at birth [26],
which the authors hypothesize is likely due to mutual maternal and offspring adjustment to a
genetically determined litter size [26]. This suggests that studies that cull pups to standardize litter
size have the potential to disturb this biological process and that the original litter size may continue
to have some influence on offspring development. In line with this, we previously demonstrated that
reducing the litter size of healthy Wistar Kyoto (WKY) rat dams at birth (from 10–14 pups per litter to
5 pups per litter) decreases offspring body weight during early life and increases adult male blood
pressure likely due to mesenteric artery stiffness and compromises bone health [27–31]. Whereas,
severely reducing litter size to 3 pups (inducing early postnatal overnutrition) increases offspring body
weight by weaning, alters cardiac structure and function and programs poor metabolic health [32,33].
Thus, there is a need to better understand the impact of reducing litter sizes to differing extents on the
subsequent outcomes of the pups.
The mechanism behind this disease programming due to reducing litter size is likely due to
its effect on milk composition. Specifically, we have recently demonstrated that both the dam and
pup can modulate the maternal milk composition [34]. Thus, dams suckling growth restricted pups
have improved milk fatty acid composition (characterized by increased LC-polyunsaturated fatty
acid (PUFA) and LC-monounsaturated fatty acid (MUFA)), which is likely to be a compensatory
mechanism aimed at supporting pup growth and organ development [34]. This finding suggests that
the decreased pup milk intake, rather than poor milk quality, results in the aforementioned long-term
disease [27–29]. Therefore, it is possible that reducing litter size at birth to 5 pups (similarly to the
reduction in litter size we observe following uteroplacental insufficiency surgery) can itself induce
changes in the early postnatal environment that has consequences for adult health outcomes and may
thus mask or exacerbate any offspring outcomes due to adverse pregnancy and/or lactational events.
Therefore, the aim of this study was to investigate the effect of reducing litter size at birth on
pup postnatal growth and development, mammary development and maternal milk composition.
We additionally characterized if there were sex-specific differences in long-term cardiometabolic and
bone health outcomes due to reducing litter size at birth and whether these outcomes were exacerbated
if the pup was suckled by a dam with altered milk quality/composition.
2. Materials and Methods
2.1. Animals
All experiments were approved by The University of Melbourne’s animal experimentation ethics
sub-committee (AEC: 02081) following the National Health and Medical Research Councils (NHMRC)
Australian code for the care and use of animals for scientific purposes. Female WKY rats (9 to
13 weeks of age) were obtained from the Animal Resources Centre (Canning Vale, WA, Australia)
and provided with a 12-h light/dark cycle at 19–22 ◦C with ad libitum access to food and water.
To generate rats with ‘normal’ and ‘altered’ milk quality/composition, rats were mated and surgery
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performed on day 18 of gestation (term = 22 days) as described previously [35]. Briefly, F0 pregnant
rats were randomly allocated to a sham (Normal milk quality/composition; Control; n = 7–8 per
group) or uteroplacental insufficiency (Altered milk quality/composition; Restricted; n = 8 per group)
group, that experience premature lactogenesis [30], and were anaesthetized with 4% isoflurane and
650 mL/min oxygen flow (reduced to 3.2% isoflurane and 250 mL/min oxygen flow when suturing to
aid in the animals recovery) to reduce the duration of anesthetic exposure and aid in recovery [35].
Rats were then allowed to deliver naturally (Figure 1a). Pups from the sham (Control) operated
dams were cross-fostered 1 day after birth (PN1) randomly onto separate dams (Control or Restricted)
where the litter size was unaltered from the surrogate (Standard) or reduced to 5 pups (Reduced)
giving rise to four experimental groups (Figure 1b); Standard litter size suckled by Normal milk
quality/composition dams (mean litter size 10.38; range 9–12 pups), Reduced litter size suckled by
Normal milk quality/composition (mean litter size 5.00; range 5 pups), Standard litter size suckled
by Altered milk quality/composition dams (mean litter size 11.50; range 7–15 pups) and Reduced
litter size suckled by Altered milk quality/composition (mean litter size 6.00; range 3–9 pups) with
n = 15–18 dams per group [17,31,36–38]. Birth weight (3.5 ± 0.4 g vs. 4.0 ± 0.04 g for Restricted and
Control dams, respectively) and litter size (8.5 ± 0.4 pups vs. 11.1 ± 0.4 pups for Restricted and Control
dams, respectively) of pups born to ligation surgery (Restricted; Altered milk quality/composition)
dams was reduced compared to sham-operated (Control; Normal milk quality/composition) dams.
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Figure 1. Study design. (a) Pregnant Wistar Kyoto (WKY) rats underwent Sham (white) or 
uteroplacental insufficiency (UPI; grey) surgery on day 18 of gestation (E18) and allowed to deliver 
naturally at birth. (b) On postnatal day 1 (PN1) pups from the Sham surgery dams were cross-fostered 
onto separate Sham (with Normal milk quality/composition) or UPI (with Altered milk 
quality/composition) dams with either an intact or reduced litter size. 
2.2. Study 1: Postnatal Study 
On the morning of PN6, one cohort of pups were removed from their dam and weighed, killed 
via decapitation, and blood was collected and pooled within litters. Aprotinin (Sigma-Aldrich; Castle 
Figure 1. Study design. (a) Pregnant Wistar Kyoto (WKY) rats underwent Sham (white) or
uteroplacental insufficiency (UPI; grey) surgery on day 18 of gestation (E18) and allowed to
deliver naturally at birth. (b) On postnatal day 1 (PN1) pups from the Sham surgery dams were
cross-fostered onto separate Sham (with Normal milk quality/composition) or UPI (with Altered milk
quality/composition) dams with either an intact or reduced litter size.
2.2. Study 1: Postnatal Study
On the morning of PN6, one cohort of pups were removed from their dam and weighed, killed via
decapitation, and blood was collected and pooled within litters. Aprotinin (Sigma-Aldrich; Castle Hill,
NSW, Australia) was added to the tubes used for plasma PTHrP analysis [39]. One pup per litter
was frozen whole and stored at −20 ◦C for whole body calcium analysis. Pup stomach contents were
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collected for fatty acid analysis. Dams were anaesthetized (Ketamine (50 mg/kg; Parnell Laboratories,
Alexandria, NSW, Australia) and Ilium Xylazil-20 (10 mg/kg; Troy Laboratories, Glendenning, NSW,
Australia)) 4–6 h after removal of the pup to allow milk to accumulate and milk was collected
following gentle massage of the left mammary gland and teats without the need for hormonal
stimulation [40], then euthanized by cardiac puncture with blood collected for subsequent analysis.
The mammary glands were dissected, weighed and the right mammary gland immediately snap
frozen in liquid nitrogen or fixed in 10% neutral buffered formalin (Perrigo; Balcatta, WA, Australia)
for histological analysis.
2.2.1. Mammary ‘Real-Time’ PCR and Histology
‘Real-time’ PCR was used to quantitate milk protein gene expression in mammary tissue on PN6
as described previously with n = 3–7 dams per group [30]. Briefly, RNA was extracted from mammary
tissue using the Polytron PT 3100 (Biolab; Clayton, VIC, Australia) homogenizer and a commercially
available kit (RNeasy Lipid Tissue Mini Kit from Qiagen; Chadstone, VIC, Australia). RNA was
then DNase treated using the Ambion DNA free kit (Life Technologies; Mulgrave, VIC, Australia).
First strand cDNA was generated from 1 µg RNA using the Superscript II Single Stranded cDNA kit
(Life Technologies). qPCR was performed then conducted against the milk protein genes Pthrp, b-casein
and a-lactalbumin with Ribosomal 18S as the reference gene [34]. The reaction was activated by heating
the mixture to 95 ◦C for 10 min, then ‘Real-time’ PCR reactions were ran for 40 cycles of 95 ◦C for 15 s
and 60 ◦C for 60 s. For relative quantification of gene expression, a multiplex comparative threshold
cycle method was employed [35]. 18S values were not different between treatments.
Fixed mammary tissue was processed into paraffin blocks, sectioned at 5 µm and stained with
hematoxylin and eosin (n = 4–5 per group). Five sections per sample were analyzed for alveolar
area and number using ImagePro Software (Medai Cybernetics; Warrendale, PA, United States of
America) [40].
2.2.2. PTHrP, Corticosterone, Calcium and Electrolyte Measurements
Plasma, milk and mammary tissue concentrations of PTHrP were quantified by a N-terminal
radioimmunoassay with a minimum detection limit of 2 pmol/L, and intra- and inter-assay coefficients
of variation of 4.8% and 13.6% respectively with n = 7–9 per group [41]. Plasma corticosterone was
measured by enzyme immunoassay validated for direct measurements in diluted plasma following
the manufacturer’s protocol (Cayman Chemical; Ann Arbor, MI, United States of America) with a
minimum detection limit of 30 pg/mL, and intra- and inter-assay coefficients of variation of 7.4% and
7.0% respectively (n = 4–8 per group). Total calcium concentrations were determined using colorimetric
spectrometry using the Synchron CX-5 Clinical System (Beckman Coulter; Lane Cove, NSW, Australia)
and ionic calcium (active or free calcium; regulated by PTHrP), sodium and potassium concentrations
were determined using ion selective electrodes correcting for pH (Ciba-Corning model 644; Cambridge,
MA, United States of America) from milk as well as from pup and maternal plasma (n = 5–8 per
group) [39,42]. Total calcium concentration in the pup body was determined after ashing using the
CX-5 Analyzer (n = 7–9 per group) [30,40]. Total protein and lactose concentrations were analyzed as
described previously with n = 4–6 per group [30].
2.2.3. Fatty Acid Analysis
Total fatty acid composition of the milk was determined by the direct trans-esterification method
of Lepage and Roy [43] as previously described [34] with n = 6–7 dams per group. Briefly, 50 to 100 µL
of milk was placed into a screw-capped Teflon-lined tube containing C23:0 as an internal standard.
After the 1-h trans-esterification procedure and recovery of the fatty acid methyl esters (FAMEs) in the
benzene phase, the FAMEs were analyzed by capillary gas liquid chromatography. FAMEs were then
separated and measured on a Shimadzu (17A) gas chromatograph with flame ionization detection.
A 50 mm × 0.25 mm BPX-70 fused silica capillary column (SGE Scientific; Ringwood, VIC, Australia)
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with a film thickness of 0.25 µm was used in conjunction with a Shimadzu on-column auto-injector.
Ultrahigh purity hydrogen was used as a carrier gas at a flow rate of 2 mL/min. A temperature
gradient program was used with an initial temperature of 170 ◦C, increasing at 3 ◦C/min to 218 ◦C.
Identification of the FAMEs was made by comparison with the retention times of chromatography
reference standard mixtures (Nu-Chek Prep; Elysian, MN, United States of America) [44].
2.3. Study 2: Lactation and Adult Study
Another cohort of pups stayed with their cross-fostered dam until weaning (PN35) and were
weighed from birth (PN1) to weaning (PN3, PN6, PN10, PN14, PN17, PN21, PN24, PN28 and PN35)
to determine pup growth and milk intake. Pups were weighed during a 1-h maternal separation
period followed by a 3-h re-feeding period. Milk intake was calculated as a percentage of pup body
weight gain after feeding compared to pre-feeding [30] and the area under the milk intake curve
was calculated between PN3 and PN17 as an index of milk consumption. After weaning, male
and female pups were housed separately. At 6 months, offspring (1 male and 1 female per litter)
underwent an intra-arterial glucose tolerance test (IAGTT) and tail-cuff blood pressure measurements
as previously described [36–38]. Rats were then weighed and anaesthetized with an intraperitoneal
injection (50 mg/kg Ketamine and 10 mg/kg Ilium Xylazil-20) and the right hind limbs were collected;
all females underwent post-mortem when they were in estrous.
2.3.1. Bone Analyses
The right hind limb was dissected to separate the femur bone from soft tissue and femur
length measured using digital calipers (n = 9–19 per group per sex). Individual femurs then
underwent peripheral quantitative computed tomography (pQCT) to measure bone volumetric content,
density and stress strain index using methods previously described [31,45–47]. Briefly, two slices of
1 mm thickness (voxel size 0.1000 mm3, peel mode 20, contour mode 1) were taken at distances of
15% and 50% from the reference line to quantify both trabecular and cortical bone tissue, respectively.
A tissue density of 280 mg/cm3 or less was identified as trabecular bone, whereas a density of
710 mg/cm3 was representative of cortical bone. Automatic density thresholding (400 mg/cm3)
was used to eliminate the effects of any soft tissue which may have remained on the femur after
dissection. Bone mineral content, density, and stress strain index (index of bone bending strength)
were then measured.
2.3.2. Plasma Analyses
Plasma were analyzed for glucose using enzymatic fluorometric analysis and insulin using a rat
insulin radioimmunoassay kit (Merck Millipore; Bayswater, VIC, Australia) as previously described
(n = 6–11 per group per sex) [38,48]. Fasting plasma glucose and insulin was taken as the average
of two-time points (10 and 5 min before injection). First-phase insulin secretion was calculated as
the incremental area under the insulin curve between 0 and 5 min after the intra-arterial injection of
glucose. Homeostasis model assessment for insulin resistance (HOMA-IR) was then determined [38].
2.4. Statistical Analysis
Data were analyzed using a two-way ANOVA to determine differences between Pup (Standard
or Reduced litter size) and Dam (Normal or Altered milk quality/composition) groups. If an
interaction was present in the two-way ANOVA, a Tukey’s post-hoc test was performed to identify
any effect of reducing litter size within each maternal group and any effect altering maternal milk
quality/composition has on pup outcomes based on litter size. Where appropriate data analysis was
performed on each sex. ANOVA statistical analysis was performed using SPSS Statistics 22 (IBM;
St Leondards, NSW, Australia). All data are presented as mean ± SEM and a p < 0.05 was assessed as
being statistically significant.
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3. Results
3.1. Growth to Weaning
As mentioned previously, dams that underwent uteroplacental insufficiency surgery gave birth to
pups that were growth restricted. Not surprisingly, however, birth weight in the four experimental
groups was not different (as only offspring from Sham-operated dams were utilized in the study)
and litter size was decreased in the groups that had their litter size Reduced at birth on PN1 and
PN6, with no differences in cannibalism across groups by PN6 (Table 1). From PN6 male (all ages)
and female (except for PN14, PN21 and PN28) body weight was decreased (−6% and −7% for males
and females, respectively) if they were suckled by a dam with Altered milk quality/composition.
Body weight at weaning was not, however, different between groups (PN35; Table 1).
Table 1. Cross-fostered litter size at postnatal day (PN) 6 and body weight from birth (PN1) to weaning













PN1 10.4 ± 0.4 11.5 ± 0.9 5.0 ± 0.0 6.0 ± 0.7 p = 0.0001 ns 1 ns
PN6 8.9 ± 0.6 8.6 ± 0.8 4.7 ± 0.3 5.25 ± 0.8 p = 0.0001 ns ns
Cannibalism 1.5 ± 0.5 2.9 ± 1.0 1.0 ± 0.7 0.8 ± 0.3 ns ns ns
Body Weight (g)
PN1
Male 4.17 ± 0.12 4.13 ± 0.10 4.23 ± 0.15 3.99 ± 0.13 ns ns ns
Female 3.87 ± 0.12 3.98 ± 0.06 3.98 ± 0.06 3.94 ± 0.11 ns ns ns
PN3
Male 5.62 ± 0.11 5.42 ± 0.15 5.41 ± 0.14 5.12 ± 0.15 ns ns ns
Female 5.38 ± 0.12 5.16 ± 0.20 5.23 ± 0.14 4.91 ± 0.14 ns ns ns
PN6
Male 8.54 ± 0.21 8.31 ± 0.23 8.66 ± 0.38 7.65 ± 0.30 ns p = 0.039 ns
Female 8.17 ± 0.21 7.91 ± 0.37 8.29 ± 5.14 7.26 ± 0.28 ns p = 0.049 ns
PN10
Male 14.6 ± 0.3 14.1 ± 0.4 14.6 ± 0.5 13.1 ± 0.5 ns p = 0.037 ns
Female 14.2 ± 0.3 13.6 ± 0.6 14.1 ± 0.5 12.7 ± 0.5 ns p = 0.040 ns
PN14
Male 22.1 ± 0.5 21.2 ± 0.6 21.5 ± 0.7 19.6 ± 1.0 ns p = 0.043 ns
Female 21.7 ± 0.4 20.6 ± 0.8 20.6 ± 0.8 19.0 ± 0.9 ns ns ns
PN17
Male 27.4 ± 0.6 26.3 ± 0.6 26.9 ± 0.8 24.5 ± 1.2 ns p = 0.030 ns
Female 26.9 ± 0.5 25.6 ± 0.7 26.0 ± 0.8 24.1 ± 1.1 ns p = 0.047 ns
PN21
Male 34.3 ± 0.6 33.6 ± 1.0 34.7 ± 0.7 31.4 ± 1.1 ns p = 0.020 ns
Female 33.8 ± 0.6 32.8 ± 1.0 33.5 ± 0.9 31.4 ± 1.0 ns ns ns
PN24
Male 43.7 ± 1.1 42.3 ± 0.9 44.3 ± 1.0 39.2 ± 1.4 ns p = 0.004 ns
Female 42.1 ± 0.8 40.4 ± 1.1 42.4 ± 1.1 38.5 ± 1.2 ns p = 0.010 ns
PN28
Male 58.7 ± 1.2 57.4 ± 1.1 59.6 ± 1.2 54.0 ± 1.8 ns p = 0.011 ns
Female 54.9 ± 1.0 54.1 ± 1.4 55.0 ± 1.4 51.3 ± 1.3 ns ns ns
PN35
Male 87.7 ± 1.7 86.6 ± 1.7 87.1 ± 1.3 82.8 ± 2.8 ns ns ns
Female 79.1 ± 1.2 77.8 ± 1.8 77.0 ± 1.4 75.7 ± 1.8 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is
not significant. 1 ns is not significant.
3.2. Mammary Structure and Maternal Plasma Analysis
An interaction between Dam and Pup was identified in mammary weight, where it was decreased
in Reduced litter size pups suckled by Normal milk quality/composition dams compared to Standard
litter size pups suckled by Normal milk quality/composition dams (−40%, Figure 2a; Tukey’s post-hoc).
There was, however, no difference in mammary weight between Standard litter size pups suckled
by Altered or Normal milk quality/composition dams; likely due to an increased alveolar number
(+25%) in Altered milk quality/composition dams, but not area (Table 2). There were no differences in
maternal plasma PTHrP and total calcium between groups (Table 2). An interaction between Dam and
Pup was identified in maternal ionic calcium, whereby it was increased in Reduced litter size pups
suckled by Normal milk quality/composition dams compared to Standard litter size pups suckled
by Normal milk quality/composition dams (+36%) and Reduced litter size pups suckled by Altered
milk quality/composition dams (+97%), but was decreased in Reduced litter size pups suckled by
Nutrients 2019, 11, 118 7 of 19
Altered milk quality/composition dams compared to Standard litter size pups suckled by Altered
milk quality/composition dams (−40%; Figure 2b; Tukey’s post-hoc). Maternal corticosterone (Table 2)
along with mammary PTHrP (mRNA and protein; Table 2 and Figure 2c) were not affected by litter size
or maternal treatment. A main Dam effect was identified in mammary a-lactalbumin gene abundance,
where it was decreased in Altered milk quality/composition dams (−51%; Figure 2d). An interaction
between Dam and Pup was identified in mammary b-casein, which was lower in Standard litter size
pups suckled by Altered milk quality/composition dams (−65%) and Reduced litter size pups suckled
by Normal milk quality/composition dams (−59%) compared to Standard litter size pups suckled by
Normal milk quality/composition dams (Figure 2e; Tukey’s post-hoc).
3.3. Pup Plasma Analysis and Milk Consumption
Milk PTHrP tended to be increased in dams suckling Reduced litter size pups (Figure 3a; p = 0.060,
two-way ANOVA). Milk Na+/K+, ionic and total calcium, total protein and lactose were not affected
by maternal milk quality/composition or litter size (Table 2). A main Pup effect was identified in pup
plasma PTHrP, where it was increased in Reduced litter size pups (+69%; Figure 3b). This finding
was in conjunction with main Pup effects in pup ionic calcium and total body calcium, where they
were decreased in Reduced litter size pups (−35% and −5%, respectively; Figure 3c,d). Milk intake in
both male and female pups were not affected by maternal milk quality/composition or pup litter size
(Figure 3e,f).













Maternal (n = 4–9 per group)
Plasma PTHrP (pmol/L) 8.2 ± 0.4 9.1 ± 1.2 10.5 ± 0.8 9.6 ± 0.7 ns 1 ns ns
Plasma total calcium (mmol/L) 2.6 ± 0.08 2.6 ± 0.04 2.6 ± 0.05 2.4 ± 0.04 ns ns ns
Plasma corticosterone (ng/mL) 593 ± 59 726 ± 106 551 ± 86 553 ± 80 ns ns ns
Mammary (n = 3–6 per group)
Alveolar number 14.5 ± 1.6 15.9 ± 0.8 11.4 ± 1.2 16.5 ± 1.7 ns p = 0.038 ns
Alveolar area 75.2 ± 3.0 75.1 ± 1.9 79.8 ± 6.5 78.5 ± 3.9 ns ns ns
PTHrP mRNA 1.0 ± 0.1 0.8 ± 0.3 1.1 ± 0.2 1.4 ± 0.3 ns ns ns
Milk (n = 4–8 per group)
Na/K 7.6 ± 1.2 6.5 ± 1.6 9.8 ± 2.5 6.4 ± 0.9 ns ns ns
Ionic calcium (mmol/L) 8.9 ± 0.6 8.7 ± 1.0 7.4 ± 0.9 9.1 ± 0.4 ns ns ns
Total calcium (mmol/L) 64.7 ± 4.0 65.8 ± 3.7 60.4 ± 5.6 57.9 ± 2.8 ns ns ns
Total protein (mg/L) 28.2 ± 4.4 22.0 ± 3.7 25.4 ± 4.5 28.1 ± 3.6 ns ns ns
Lactose (mM) 30.2 ± 7.9 38.4 ± 3.8 29.5 ± 6.0 41.7 ± 10.4 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM with sex pooled
per litter, where ns is not significant. 1 ns is not significant.
3.4. Milk Fatty Acid Composition
An interaction between Dam and Pup was identified in linoleic acid (LA), arachidonic acid (AA)
and total n-6 fatty acids. Specifically, levels of the individual n-6 PUFAs (LA and AA), and total
n-6 fatty acid content were increased in milk from Standard litter size pups suckled by Altered
milk quality/composition dams (+20% and +21% for LA and total n-6) and Reduced litter size pups
suckled by Normal milk quality/composition(+21%, +48% and +24%, respectively) dams compared
to Standard litter size pups suckled by Normal milk quality/composition dams (Table 3; Tukey’s
post-hoc). There was a main Pup effect in levels of the n-3 LC-PUFA docosahexaenoic acid (DHA)
which was increased in milk from dams suckling Reduced litter size pups (+31%; Table 3), but there
was no difference in total n-3 fatty acid content of the milk between groups. An interaction between
Dam and Pup was identified in long chain saturated fatty acid content, where they were decreased in
the milk of Reduced litter size pups suckled by Normal milk quality/composition dams compared to
Standard litter size pups suckled by Normal milk quality/composition dams (−24%; Table 3, Tukey’s
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post-hoc). A main Pup effect was identified in total LC-MUFA content, where it was increased in
the milk of dams suckling Reduced litter pups (+11%). The ratio of n-6:n-3 fatty acids and medium
saturated fatty acids were not affected by litter size or maternal milk quality/composition (Table 3).
The full list of fatty acids analyzed from the stomach contents are reported in Supplementary Table S1.
Nutrients 2018, 10, x FOR PEER REVIEW  8 of 21 













Figure 2. Effect reducing litter size has on maternal and mammary outcomes (n = 5–9 per group). (a) 
Mammary weight, (b) maternal ionic calcium concentrations and (c) mammary PTHrP protein 
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between sham operated (Control; Normal milk quality/composition) and uteroplacental insufficiency
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(‡ p < 0.05). Normal milk quality/composition dams denoted by white open bars and Altered milk
quality/composition dams denoted by black closed bars.
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Figure 3. Effect reducing litter size has on alcium handling and milk intake (n = 6–10 litter
averages per group, where appropriate). (a) ilk and (b) pup PTHrP co centrations, (c) pup ionic
calcium concentrations, (d) pup total body calcium and (e,f) pup milk intake. Data are analysed with a
two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and Dam (Normal
and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is not
significant. Normal milk quality/composition dams denoted by white open bars and Altered milk
quality/composition dams denoted by black closed bars.
3.5. Adult Health
Body weight at 6 months was decreased in male (−5%), but not female, offspring from
Reduced litters, which was further exaggerated by Altered milk quality/composition (−5%)
(Table 4). Femur length in both males and females was unaffected by litter size or maternal milk
quality/composition (Table 4). An interaction between Pup and Dam was identified in male and
Nutrients 2019, 11, 118 10 of 19
female trabecular mineral content, whereby trabecular mineral content was decreased in male (−14%)
and female (−12%) Reduced litter size pups suckled by Altered milk quality/composition dams
compared to Reduced litter size pups suckled by Normal milk quality/composition counterparts
(Figure 4a; Tukey’s post-hoc). A main Dam effect was identified in trabecular density in male offspring,
where it decreased in offspring suckled by Altered milk quality/composition dams (−6%; Figure 4b).
In females, an interaction between Pup and Dam was identified trabecular density, where it was
decreased in Reduced litter size pups suckled by Altered milk quality/composition dams (−8%)
compared to Reduced litter size pups suckled by Normal milk quality/composition dams (Figure 4b;
Tukey’s post-hoc). Cortical mineral content was decreased in male offspring who were suckled by
Altered milk quality/composition dams (−4%), with no change in females (Table 4). Cortical density
was unaffected by litter size or maternal milk quality/composition in both male and female offspring
(Table 4). A main Pup effect was identified in bone bending strength in male, but not female offspring,
where it was decreased in offspring of Reduced litters (−7%; Figure 4c).
Table 3. Fatty acid composition in stomach contents consumed in milk presented as a cumulative
total percentage of fatty acids on postnatal day 6 in the four cross-foster groups (n = 5–7 per group,














Linoleic (18:2n-6) 11.79 ± 0.25 14.12 ± 0.43 ‡1 14.23 ± 0.26 *2 13.85 ± 0.50 p = 0.010 p = 0.019 p = 0.002
Arachidonic (20:4n-6) 1.03 ± 0.06 1.33 ± 0.12 1.52 ± 0.08 * 1.35 ± 0.09 p = 0.014 ns 3 p = 0.023
Total n-6 PUFA 14.4 ± 0.4 17.4 ± 0.7 ‡ 17.9 ± 0.4 * 17.1 ± 0.7 p = 0.009 ns p = 0.003
Omega-3 PUFA
α-linolenic (18:3n-3) 1.40 ± 0.06 1.48 ± 0.09 1.49 ± 0.05 1.46 ± 0.11 ns ns ns
Eicosapentaenoic (20:5n-3) 0.21 ± 0.01 0.17 ± 0.03 0.21 ± 0.02 0.18 ± 0.04 ns ns ns
Docosahexaenoic (22:6n-3) 0.41 ± 0.03 0.45 ± 0.06 0.55 ± 0.04 0.58 ± 0.09 p = 0.047 ns ns
Total n-3 PUFA 2.4 ± 0.09 2.4 ± 0.18 2.7 ± 0.15 2.7 ± 0.21 ns ns ns
n-6:n-3 6.07 ± 0.15 7.11 ± 0.27 6.58 ± 0.28 6.63 ± 0.54 ns ns ns
Total LC-MUFA 22.4 ± 0.9 22.4 ± 1.4 25.8 ± 0.9 23.9 ± 0.8 p = 0.032 ns ns
Saturated Fatty Acids
Medium (6–12) 19.8 ± 1.0 21.1 ± 0.7 21.1 ± 0.7 20.8 ± 0.9 ns ns ns
Long (14–20) 40.4 ± 1.1 35.2 ± 2.1 30.9 ± 1.4 * 34.2 ± 1.9 p = 0.006 ns p = 0.022
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters)
and Dam (Normal and Altered milk quality/composition) groups, with a Tukey’s post-hoc test used to identify
where interactions lie. Data presented as the mean ± SEM with sex pooled per litter, where ns is not significant.
Significant differences between Standard and Reduced litter pups are indicated by an asterisk (* p < 0.05) and
differences between sham operated (Control; Normal milk quality/composition) and uteroplacental insufficiency
surgery (Restricted; Altered milk quality/composition) dams are indicated with a double dagger (‡ p < 0.05).
Also see Table S1 for individual fatty acids. 1 p < 0.05 Standard-on-Altered vs. Standard-on-Normal; 2 p < 0.05
Reduced-on-Normal vs. Standard-on-Normal; 3 ns is not significant.
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Figure 4. Effect reducing litter size has on adult offspring bone (n = 9–19 per group, with n = 1
representing 1 male and female per litter) and cardiometabolic health (n = 5–11 per group, with n = 1
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representing 1 male and female per litter). (a,b) Trabecular mineral content and density, (c) bone
bending strength, (d) homeostasis model assessment for insulin resistance (HOMA-IR) and (e) blood
pressure at 6 months. Data are analysed with a two-way ANOVA reporting differences between
Pup (Standard and Reduced litters) and Dam (Normal and Altered milk quality/composition)
groups, with a Tukey’s post-hoc test used to identify where interactions lie. Data presented as the
mean ± SEM, where ns is not significant. Significant differences between sham operated (Control;
Normal milk quality/composition) and uteroplacental insufficiency surgery (Restricted; Altered
milk quality/composition) dams are indicated with a double dagger (‡ p < 0.05). Normal milk
quality/composition dams denoted by white open bars and Altered milk quality/composition dams
denoted by black closed bars, with data from males on the left-hand side and data from females on the
right-hand side.
Fasting glucose at 6 months was not different between groups in either males or females (Table 4).
In male, but not female offspring, a main Dam effect was identified in fasting insulin concentrations
where it was higher in offspring who had been suckled by Altered milk quality/composition dams
and also tended to be lower in Reduced litter size pups (Table 4; p = 0.070). Similarly, glucose AUC
tended to be higher and first phase insulin tended to be lower in male offspring that were suckling
Altered milk quality/composition dams (Table 4; p = 0.080 and p = 0.069, respectively), with no changes
in females. HOMA-IR at 6 months tended to be increased in offspring who had been suckled by
Altered milk quality/composition dams (p = 0.076) and decreased in Reduced litter size offspring
(p = 0.057; Figure 4d). Interestingly, a main Pup and Dam effect were observed in male blood pressure,
where it was increased both in Reduced litter male offspring compared to Standard litter size offspring
(+7%) and in offspring who had been suckled by Altered milk quality/composition dams compared to
Normal milk quality/composition dams (+5%; Figure 4e). HOMA-IR and blood pressure were not
different between groups in female offspring (Figure 4d,e).
Table 4. Adult offspring physiology in the four cross-foster groups at 6 months (n = 9–19 per group for













Body Weight (g) Male 386.1 ± 7.0 368.9 ± 2.3 368.4 ± 7.0 351.8 ± 9.5 p = 0.020 p = 0.023 ns
Female 239.3 ± 4.1 233.1 ± 6.5 238.3 ± 3.7 226.9 ± 4.7 ns 1 ns ns
Bone Parameters
Femur Length (mm) Male 37.01 ± 0.12 36.79 ± 0.23 36.61 ± 0.21 36.01 ± 0.16 ns ns ns
Female 33.09 ± 0.14 32.75 ± 0.19 32.69 ± 0.14 32.42 ± 0.15 ns ns ns
Cortical content (mg·mm−1) Male 10.67 ± 0.15 10.63 ± 0.28 10.74 ± 0.18 9.93 ± 0.13 ns p = 0.005 nsFemale 7.87 ± 0.09 7.79 ± 0.11 7.90 ± 0.12 7.49 ± 0.11 ns ns ns
Cortical density (mg (mm3)−1)
Male 1409.4 ± 1.8 1413.3 ± 3.7 1412.6 ± 3.8 1407.9 ± 1.9 ns ns ns
Female 1407.9 ± 2.5 1412.4 ± 1.2 1404.8 ± 1.8 1399.1 ± 2.0 ns ns ns
Metabolic Parameters
Fasting plasma glucose (mmol·L−1) Male 5.77 ± 0.21 5.81 ± 0.19 5.52 ± 0.19 5.64 ± 0.27 ns ns nsFemale 5.15 ± 0.18 5.69 ± 0.18 5.50 ± 0.20 5.64 ± 0.22 ns ns ns
Fasting plasma insulin (ng·ML−1) Male 1.28 ± 0.24 1.82 ± 0.17 0.91 ± 0.12 1.32 ± 0.33 p = 0.070 p = 0.048 nsFemale 1.07 ± 0.24 1.23 ± 0.23 1.09 ± 0.14 1.23 ± 0.21 ns ns ns
Glucose AUC
Male 757.3 ± 87.0 795.6 ± 79.8 742.2 ± 67.1 989.6 ± 62.1 ns p = 0.080 ns
Female 812.9 ± 74.1 701.9 ± 70.1 689.3 ± 52.8 635.2 ± 45.2 ns ns ns
First phase insulin AUC Male 14.25 ± 1.54 10.01 ± 2.08 11.31 ± 1.92 8.53 ± 1.17 ns p = 0.069 ns
Female 13.91 ± 2.02 11.29 ± 2.05 13.81 ± 1.74 14.01 ± 1.84 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is
not significant. 1 ns is not significant.
4. Discussion
Providing offspring with adequate and appropriate nutrition during lactation is essential for
long-term health, with both over- and undernutrition increasing disease susceptibility [14–16]. We have
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previously demonstrated that both the dam and suckling pup can influence maternal milk composition,
and that these effects generally represent an attempt to improve pup growth and development [34].
The current study has demonstrated that reducing litter size at birth, regardless of whether the dam
has normal or altered milk quality/composition impairs pup calcium homeostasis, which may reduce
bone bending strength in male offspring. Additionally, these adult Reduced litter males appear to
have increased cardiovascular disease risk and decreased diabetes risk. Furthermore, altered milk
quality/composition (induced by uteroplacental insufficiency surgery) similarly programs poor bone
health, high blood pressure and impairs glucose tolerance/insulin sensitivity. These finding are likely
due to differential influences of the predetermined litter size at birth [26] and effects on milk quality.
This highlights that caution needs to be taken when interpreting animal studies that focus on early life
nutrition, as the experimental approach may independently modulate milk nutrition and quality.
4.1. Effects of Reducing Litter Size
It is important to note that as all dams underwent a surgical procedure (sham or ligation) and
all litters were cross-fostered the effects reported are as direct consequences of either the maternal
surgery (resulting in altered milk quality/composition) or reduced litter size, thus we have adequately
accounted for all possible confounders, such as stress, across experimental groups. Additionally,
growth restricted pups were not included in the study, only pups born from sham-operated dams that
have intact or reduced litter sizes when cross-fostered, which would limit any changes observed in
pups suckled by dams that underwent uteroplacental insufficiency surgery to the lactation environment
they are exposed to in early postnatal life. Reducing litter size is commonly used in the developmental
programming field, however recent studies demonstrate that this can independently program disease
susceptibility [27–30]. In the current study we report dynamic changes in pup calcium homeostasis and
maternal milk composition as a result of reducing the litter size to 5 pups. Interestingly, despite these
changes in milk composition, no changes in postnatal body weight was observed, which suggests
that other intrinsic hormonal factors may be responsible for maintaining pup growth that requires
further studies. The reduction in mammary gland weight in Normal milk quality/composition
dams suckled by Reduced litter pups may be due to the decreased b-casein gene expression, which is
known to regulate mammary differentiation and is a regulator of milk protein gene expression [49].
However, this likely did not alter alveolar area or number as lactogenic differentiation is completed by
PN6 [49]; although studies at earlier postnatal ages may reveal altered mammary structure. Despite
no changes in maternal PTHrP, dams suckled by Reduced litter pups had increased milk PTHrP.
Previous studies have demonstrated that milk PTHrP is not absorbed by the intestines into the pups
circulation [50], suggesting that the increased pup PTHrP concentrations we report are independent
of milk PTHrP content. This increased pup PTHrP is likely to stimulate bone resorption, and thus
calcium release, in an attempt to increase plasma calcium concentrations, as shown in a previous
study [51], but has also been shown to result in decreased postnatal body calcium content [52].
Interestingly, the increased maternal ionic calcium concentrations in Normal milk quality/composition
dams suckled by Reduced litter pups are likely an attempt to increase milk calcium concentrations
to compensate for this deficit. This, however, did not translate to increased milk calcium content at
the time point investigated in this study, highlighting that milk composition needs to be assessed
at additional postnatal ages. Nevertheless, the increased milk PTHrP in dams suckling Reduced
litter pups would facilitate increased intestinal calcium reabsorption to increase pup plasma calcium
concentrations, preventing any further bone breakdown. These data may highlight why the Reduced
litter size pups suckled by Normal milk quality/quantity dams do not exhibit the same deficits in
adult bone mineral content and density that are observed in the Reduced litter size pups suckled by
Altered milk quality/quantity. Despite this, however, Reduced litter male offspring have decreased
bending strength, indicative of increased fracture risk and thus poor bone health, suggesting that any
compensatory changes in milk composition were not sufficient to fully prevent bone deficits.
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In addition to alterations in pup calcium homeostasis in the Reduced litter group, we also report
changes in milk fatty acid content, highlighting that Reducing litter size has profound effects on
maternal milk quality. Interestingly, milk n-6 fatty acid content was increased in the Reduced litter
size pups suckled by Normal milk quality/quantity dams. This is significant, since increased n-6
fatty acid intakes have been associated with increased fat deposition in early life [11]. High intakes
of n-6 PUFA during lactation also influence lipid tissue status and modulate metabolic pathways
that can lead to diabetes and cardiovascular disease [11]. It is important to note, however, that it
is the balance of omega-6 and omega-3 PUFA in the diet that appears to be the more important
determinant of physiological effects than levels of either PUFA type alone. In the current study,
the n-6:n-3 ratio was not altered, at least at this age, by either litter size or maternal uteroplacental
insufficiency surgery. This suggests that the observed changes in milk PUFA composition may not
be a major factor contributing to the male onset cardiovascular disease we report, but may instead
be due to the decreased post-weaning growth trajectory. Interestingly, reducing litter size increased
milk LC-MUFA and DHA (Reduced litter size pups suckled by Normal milk quality/quantity dams
only) content, which is known to have beneficial effects on metabolic function during critical periods
of development [11]. The improved metabolic health in Reduced litter size pups suckled by Normal
milk quality/quantity dams male offspring may also be attributed to increased milk Pentadecanoic
acid (15:0) and reduced Palmitic acid (16:0) both of which are known to reduce the risk of type 2
diabetes [53]. This may explain why the Reduced litter size male offspring appear to have a decreased
risk of developing diabetes.
4.2. Effects of Altered Milk Quality/Composition
Surprisingly alterations in milk quality/composition, induced by maternal uteroplacental
insufficiency surgery, resulted in very few changes in milk composition compared to the large
number of changes associated with reducing litter size and slowing offspring postnatal growth.
In the current study, we report that dams with altered milk quality/composition have decreased
mammary a-lactalbumin gene abundance. If this translates to decreased milk α-lactalbumin protein
then this may, at least in part, contribute to the poor adult bone health we observed in male offspring
reared by Altered milk quality/composition dams. Specifically, as α-lactalbumin binds calcium [54]
it is possible that decreased milk α-lactalbumin impairs calcium delivery to the pup, compromising
bone mineralization and development. This poor bone health was only apparent in Reduced litter size
pups suckled by Altered milk quality/composition dams, likely because the effect was compounded
by the decreased maternal ionic concentrations that may have compromised calcium delivery at later
lactational ages. Interestingly, a recent study demonstrated that supplementing 6-week old obese
diabetic Zucker rats with α-lactalbumin for 13 weeks improves metabolic function [55]; highlighting
the benefits of α-lactalbumin on metabolic health. If the inverse is also true, and rats are exposed to
decreased α-lactalbumin during development, it is possible that this may contribute to the increased
risk of adult metabolic disease we observed in our rats. In addition, the increased n-6 fatty acid intake
in Standard litter size pups suckled by Altered milk quality/quantity dams during lactation may also
contribute to the increased blood pressure and impaired insulin sensitivity in male offspring [11].
As the female offspring suckled by Altered milk quality/composition dams caught up in body weight
prior to weaning they may be protected against developing cardiometabolic disease, due to the benefits
of early accelerated growth for long-term cardiometabolic health [36,56–58].
4.3. Study Limitations
Despite our study demonstrating that reducing the litter size from 9 pups to 5 pups alters milk
quality/composition and has implications for long-term offspring health, further studies are required
to investigate the effects of the more common practice of reducing litter sizes to 8–10 pups from original
litter sizes of 12–20 pups, since this also has the potential to influence milk quality/quantity and thus
offspring outcomes. Nevertheless, the findings of the current study highlight the potential impact
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reducing litter size, independent of other neonatal factors, has on programming offspring outcomes.
An important factor that was not taken into consideration in the present study is the impact of offspring
sex on milk composition, due to difficulties in controlling for this in our large litter bearing animal
model. Indeed, several epidemiological and experimental (with smaller litter bearing animals) studies
have well demonstrated differences in milk composition between male and female infants [59,60];
demonstrating that infant sex has a significant impact on milk quality. This highlights the need for
well-controlled human and animal studies to identify alterations in milk composition between infant
sexes in several different pregnancy complications.
A limitation of the current study is that maternal behavior was not evaluated throughout lactation.
This is particularly important, as the quality and quantity of maternal care during lactation can
impact on offspring behavioral, endocrine and neural development (see review by Curley and
Champagne [61]). Specifically, a recent study demonstrated that dams whose litters were reduced to
3 pups (to induce postnatal overnutrition) have improved maternal care, characterize by increased
time devoted to arched nursing and licking pups [62]. Not surprisingly the pups had early accelerated
growth and were overweight by PN60, as indicated by increased adiposity, and were hyperglycemic
and hyperleptinemic [62]. These findings are however difficult to compare directly to the results of
the current study where the Reduced litter pups had decreased postnatal growth, which suggests
that the extent of litter size reduction in the current study is unlikely to have resulted in improved
maternal care.
5. Conclusions
This study demonstrates that reducing pup litter size and altered maternal milk
quality/composition differentially program poor adult offspring health, which is likely due to altered
milk quality. Specifically, reducing the litter size alters milk composition, impairs pup calcium
homeostasis and programs poor bone health, which likely contributes to the lower diabetes risk and
poor cardiovascular health. Alterations in maternal milk quality/composition, on the other hand,
programs poor adult bone and cardiovascular health and reduces glucose tolerance/insulin sensitivity.
This study highlights the need for appropriate controls in developmental research to clearly ascertain
phenotypes in the model. Importantly, controls implemented to standardize outcomes across treatment
groups may independently program disease susceptibility, which limit their translatability. Therefore,
care must be taken in interpreting findings from studies that standardize litter size as it may mask
subtle effects on cardiometabolic health.
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